EUPRAXIA PHARMACEUTICALS INC. Proceeds from Issuance of Private Placement
EUPRAXIA PHARMACEUTICALS INC. (EPRX) reported Proceeds from Issuance of Private Placement of $31.71 million for the 12-month period ending 2024-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2026-03-13
| Period end | Proceeds from Issuance of Private Placement 12 month |
|---|---|
| 2024-12-31 | $31.71M 40-F · filed 2026-03-13 |